Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTK787/ZK222584 in Unresectable Malignant Mesothelioma
NCT00053885Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in malignant mesothelioma, sponsored by Cancer and Leukemia Group B. Started Jul 2003; status: completed.
02
Drugs
vatalanib
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00053885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053885.